MedPath

Pre-treatment in prevention of post spinal shivering with oral gabapentin and oral tramadol.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/05/067831
Lead Sponsor
Dr Lovepreet Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age more than 18 years

2.American Society of Anaesthesiologists (ASA) I AND II

3.Elective surgery under spinal anesthesia

Exclusion Criteria

1.History of allergy to opioids and gabapentin

2.Patient already on tramadol and gabapentin 3.History of opioids abuse

4.Febrile patient

5.Patient with psychiatric illness or communication difficulty

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the onset of shivering after spinal anaesthesia between the groupsTimepoint: for 2-4 hours after spinal anaesthesia
Secondary Outcome Measures
NameTimeMethod
1.To observe the severity of shivering <br/ ><br>2.To observe the therapeutic dose of fentanyl to control shivering <br/ ><br>Timepoint: Intra operative for 2-4 hours
© Copyright 2025. All Rights Reserved by MedPath